Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment

Clinical and Experimental Rheumatology

Volumn 19, Issue 5 SUPPL. 24, 2001, Pages

  Savgan Gurol E ^a   Kasapcopur O ^a,b   Hatemi, S ^a   Ercan, O ^a   Caliskan S ^a   Sever, L ^a   Ozdogan H ^a   Arisoy, N ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Colchicine treatment; Familial Mediterranean fever; Growth; Insulin like growth factor 1

Indexed keywords

COLCHICINE; SOMATOMEDIN C;

AGE DETERMINATION; ARTICLE; BODY HEIGHT; BODY MASS; CHILD; COMPARATIVE STUDY; DRUG EFFECT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GROWTH; HOSPITALIZATION; HUMAN; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

AGE DETERMINATION BY SKELETON; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COLCHICINE; COMPARATIVE STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GROWTH; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T;

EID: 21544480033     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. GEDALIA A, ADAR A, GERODISCHER R: Familial Mediterranean fever in children. J Rheumatol 1992; 19 (Supp.): 1-9.
2. ARISOY N, KASAPCOPUR Ö, SEVER L, CALISKAN S, YAZICI H, ÖZDOGAN H: Familial Mediterranean fever in Turkish children. In SOHAR E, GAFNI J, PRAS M (Eds.): Proceedings of the First International Conference on Familial Mediterranean Fever. London, Freund, 1997: 168-72.
3. SAATCIU, OZEN S, OZDEMIR S et al.: Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 1997; 156: 619-23.
4. MAJEED HA, RAWASHDESH M, EL SHANTI H, QUBAIN H, KHURI-BULOS N, SHAHIN HM: Familial Mediterranean fever: the expanded clinical profile. QJM 1999; 92: 309-18.
5. SAMUELS J, AKSENTIJEVICH I, TOROSYAN Y et al.: Familial Mediterranean fever at the millenium: Clinical spectrum, ancient muttaions and a survey of 100 American referrals to the NIH. Medicine 1998; 77: 268-97.
6. ZEMER D, LIVNEH A, DANON Y, PRAS M, SOHAR E: Long term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991; 34: 973-7.
7. BEN-CHETRIT E, LEVY M: Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 1991;20:241-6.
8. UNDERWOOD LE: Growth retardation in chronic diseases: possible mechanisms. Acta Pediatrica 1999; 428 (Suppl.): 93-6.
9. CIMAZ R, RUSCONI R, CESANA B et al.: A multicenter study on insulin like growth factor-1 serum levels with chronic inflammatory diseases. Clin Exp Rheumatol 1997; 15:691-6.
10. PRAS E, LIVNEH A, BALOW JE et al.: Clinical differences between north African Jews and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998; 75: 216-9.
11. NEYZI O, BINYILDIZ P, ALP H: Percentile curves of Turkish children. 1st Tip Fak Mecm 1978; 41: 74.
12. GREULICH WW, PYLE SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd ed., Stanford University Press, 1959.
13. DIRESKENELI H, ÖZDOGAN H, KORKMAZ C, AKOGLU T, YAZICI H: Serum soluble intercellular adhesion molecule I and interleukin 8 levels in familial Mediterranean fever. J Rheumatol 1999; 26: 1989-6.
14. KIRAZ S, ERTENLI I, ARICI M et al.: Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 1998; 16: 721-4.
15. MURATA M: Population specific reference values for bone age. Acta Pediatr 1997; 423 (Suppl.): 113-4.
16. BENSO L, VANELLIS, PASTORIN L, BENSO A, MILANI S: Variation of bone age progression in healthy children. Acta Pediatr 1997; 423 (Suppl.): 109-12.